搜期刊

ASSAY and Drug Development Technologies CA PubMed AJ SCIE JCR:Q3 JCR:Q4 中科院4区
发文量 1,528
被引量 21,354
影响因子(2023) 1.597

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: -Assay design, target development, and high-throughput technologies- Hit to Lead optimization and medicinal chemistry through preclinical candidate selection- Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis- Approaches to assays configured for gene families, inherited, and infectious diseases- Assays and strategies for adapting model organisms to drug discovery- The use of stem cells as models of disease- Translation of phenotypic outputs to target identification- Exploration and mechanistic studies of the technical basis for assay and screening artifacts

  • 主办单位: MARY ANN LIEBERT, INC
  • 出版地区: United States
  • 出版周期: 双月刊
  • 别名: 测定和药物开发技术
  • 国际标准连续出版物号: ISSN 1540-658X
  • 创刊时间: 2002年
收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
分析评价
  • 1
  • 2
  • 3
目录
封面
2024年05期
共:4篇

      不详

    • 217-228
    • Qureshi, SundusAlavi, Seyed EbrahimMohammed, Yousuf

      229-245
    • Krishnan, JaneshaPoomalai, PraveenaRavichandran, AshwinReddy, AishwaryaSureshkumar, Raman

      246-264
    • Mucke, Hermann A.M.

      265-275
2024年05期

2024年05期